Syros Pharmaceuticals Inc. (SYRS)
Market Closed
19 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary 
LSE $
0. 00
-0
-75%
$
10.73K Market Cap
4.89 P/E Ratio
- Div Yield
6,918 Volume
-4.76 Eps
$ 0
Previous Close Analysts:
Want to track SYRS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
SYRS Earnings Reports FAQ
What is the earnings per share (EPS) for SYRS?
The current EPS is -4.76.
What is the company's earnings growth rate?
Syros Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Syros Pharmaceuticals Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Syros Pharmaceuticals Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for SYRS at this time, as Syros Pharmaceuticals Inc has no recent EPS data to calculate it.
